GVR Report cover Live Cell Encapsulation Market Size, Share & Trends Report

Live Cell Encapsulation Market Size, Share & Trends Analysis Report By Polymer Type (Alginate, Chitosan, Cellulose Sulfate, Others), By Application, By Technique, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453973
  • Number of Pages: 0
  • Format: Electronic (PDF)

Live cell encapsulation is a process that involves encasing living cells within a protective material or structure. This technology has the potential to revolutionize many areas of research and medicine, as it allows for the safe and controlled delivery of cells and cell-based therapies. There are many different materials and methods used for live cell encapsulation. Some commonly used materials include hydrogels, liposomes, and microcapsules. Hydrogels are hydrophilic, cross-linked polymeric materials that can be made from a variety of natural or synthetic polymers. They are biocompatible and can provide a suitable environment for cell growth and survival. Liposomes, on the other hand, are spherical vesicles composed of a phospholipid bilayer that can encapsulate both hydrophilic and hydrophobic materials. Microcapsules are also spherical structures, but they are composed of a polymeric material that surrounds the cells or active agents.

One of the key advantages of live cell encapsulation is that it allows for the controlled release of cells or bioactive molecules. This is particularly useful in the field of cell-based therapies, where the goal is to deliver therapeutic cells to a specific location in the body while keeping them protected from the host's immune system. For example, live cell encapsulation has been used to deliver insulin-producing cells to patients with diabetes, and it has also been used to deliver cells that produce dopamine to patients with Parkinson's disease. Another area in which live cell encapsulation is being used is tissue engineering. In this field, live cell encapsulation is used to create functional tissue constructs, such as skin, cartilage, and blood vessels, by encapsulating living cells within a supportive material that mimics the extracellular matrix.

The live cell encapsulation market is experiencing growth as a result of increasing investments in new therapeutics and the rise in chronic diseases. The technique of live cell encapsulation involves encasing living cells within a semi-permeable membrane, which can be used to control the delivery of cells in cell transplantation or organ replacement. In addition, BIO INX recently launched a new biocompatible material for live cell encapsulation in November 2022. Compared to protein encapsulation, live cell encapsulation allows for controlled and sustained cell delivery, leading to safe and effective results. In January 2019, BioTime, Inc. launched pluripotent cells which can be used in drug discovery, research, and regenerative medicine therapies, resulting in the company having a better market attention for live cell encapsulation market.

The biotechnology market is also experiencing significant growth in the field of live cell encapsulation, as researchers and companies invest in the development and clinical efficacy of this technology. The use of live cell encapsulation in the treatment of chronic diseases such as cancer, autoimmune diseases, and type 1 diabetes is particularly promising and is expected to drive market growth. For example, in type 1 diabetes, microencapsulation of insulin-producing cells can protect them from destruction by the immune system and allow them to respond to glucose levels by producing insulin. A study published in the NGP Asia Material in May 2022 found that porous microcapsules encasing cells were effective in the treatment of diabetes, and researchers believe that this method will be widely used in the clinic. The market for live cell encapsulation technology is expected to experience growth as it becomes increasingly utilized in the development of therapies for chronic diseases. This trend is supported by recent developments such as the announcement by PharmaCyte Biotech in July 2022, that it has commenced the first phase of a two-phase pig study investigating the use of live cell encapsulation technology for the treatment of diabetes. This study is a significant step in the development of therapies that could potentially transform the treatment of diabetes and other chronic diseases, further driving the growth of the live cell encapsulation market in the biotechnology industry.

To enable the growth and creation of highly precise and functional microstructure with live cells, BIO INX, a major supplier of biocompatible materials, and Nanoscribe, a leader in microfabrication technology, have expanded their collaboration with the introduction of HYDROBIO INX N400 in November 2022. This product promises to benefit those in the field of live cell encapsulation and regenerative medicine by giving them access to a powerful tool to generate precise, usable, and stable microstructures that contain living cells.

On the basis of geography, the global live cell encapsulation market is divided into several regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America is expected to dominate the market. The growth in this region is attributed to the increasing government and corporate investments in countries such as the U.S., Canada, continued technological innovations in live cell encapsulation, and the presence of major market players in the region. Furthermore, the increasing prevalence of chronic diseases and growing awareness about the benefits of live cell encapsulation are expected to drive market growth in these regions.

                                           Live Cell Encapsulation Market Segmentation



Polymer Type

  • Alginate
  • Chitosan
  • Cellulose Sulfate
  • Others



  • Drug Delivery
  • Regenerative Medicine
  • Cell Transplantation
  • Probiotics


  • Simple Dripping,
  • Electrostatic Dripping
  • Coaxial Airflow


  • North America (U.S., Canada),
  • Europe (UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway)
  • Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)
  • Latin America (Brazil, Mexico, Argentina),
  • Middle East & Africa (Saudi Africa, South Arabia, UAE, Kuwait)


The live cell encapsulation market is a highly competitive and dynamic market, with the presence of several well-established players. Some of the key players operating in the market include BioTime, Inc., Thermo Fisher Scientific, Merck KGaA, Lonza Group, PromoCell GmbH, STEMCELL Technologies Inc., Corning Incorporated, Merck Millipore, Fujifilm Wako Pure Chemical Corporation, NanoEnTek Inc, and InSphero AG. These key players are focusing on product development, innovation, and strategic collaborations to gain a competitive edge in the market.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon